Staten Biotechnology

Staten Biotechnology aims to develop novel and innovative strategies for the treatment of dyslipidemia

Biotech & Life Sciences

Sector

Seed

Stage

Biotechnology

Model

01Company Overview

Staten Biotechnology aims to develop novel and innovative strategies for the treatment of dyslipidemia.

02Backed By1 investor

03Similar Companies

LP

Lipigon Pharmaceuticals

Biotech & Life Sciences

→

DP

RP

D

RP

04Startup DNA

6

signals

Sectors
Business Model
Technology